IMMUNOQUEST THERAPEUTICS AS
Signals
- Negativ egenkapital 2025 Bokført egenkapital er negativ (−1,3 mill kr).
- Driftsunderskudd 2025 Siste driftsresultat er negativt (−2,3 mill kr).
- Ingen revisor Selskapet har ingen registrert revisor. Vanlig for små AS som har valgt bort revisjon, men verdt å merke seg.
IMMUNOQUEST THERAPEUTICS AS is registered as a limited company in Oslo, Oslo with organisation number 931892266. The business is classified under research and experimental development on natural sciences and engineering (NACE 72.100). The company was incorporated in 2023. Registered share capital is NOK 43,000, divided into 43019 shares. The company's stated purpose is: “Forskning og utvikling av kreftbehandling.”. The most recent filed accounts, for the 2025 financial year, show NOK 0 in revenue and NOK −2.3m in operating profit.
Key figures · 2025
Financial health · 2025
Solidity capped at Weak because equity is below NOK 100,000.
Who owns IMMUNOQUEST THERAPEUTICS AS?
IMMUNOQUEST THERAPEUTICS AS has 3 registered shareholders:
- INVEN2 AS 60.0%
- THE N AS 20.0%
- JON AMUND KYTE 20.0%
Frequently asked questions about IMMUNOQUEST THERAPEUTICS AS
Who owns IMMUNOQUEST THERAPEUTICS AS?
INVEN2 AS is the largest registered owner, with 60.0%.
What is the revenue of IMMUNOQUEST THERAPEUTICS AS?
IMMUNOQUEST THERAPEUTICS AS had revenue of NOK 0 in 2025.
Where is IMMUNOQUEST THERAPEUTICS AS based?
IMMUNOQUEST THERAPEUTICS AS has its business address in Oslo.
Property
292 companies are registered at this address.
The address this company is registered at, from the company register and matched against the cadastre. It does not say who owns the property — a company may be a tenant, and the address is often its accountant's. Source: Brønnøysundregistrene and © Kartverket.
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 02.09.2026.